S100A11 activates the pentose phosphate pathway to induce malignant biological behaviour of pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the most refractory malignancies and has a poor prognosis. In recent years, increasing evidence has shown that an imbalance of metabolism may contribute to unrestricted pancreatic tumour progression and that the pentose phosphate pathway (PPP) plays...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Xue, Guo, Hong, Liu, Zhuang, Qin, Zilan, Cong, Yuyang, Ren, Naihan, Zhang, Yuxiang, Zhang, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233679/
https://www.ncbi.nlm.nih.gov/pubmed/35752610
http://dx.doi.org/10.1038/s41419-022-05004-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233679/
https://www.ncbi.nlm.nih.gov/pubmed/35752610
http://dx.doi.org/10.1038/s41419-022-05004-3

Ejemplares similares